O
besity is a leading health problem in the United States because of its increasing prevalence (1) and etiologic role in many chronic health conditions (2) . In the general U.S. adult population, obesity is associated with a higher risk for premature death (3-5). The effect of obesity on mortality in both elderly and African American persons is less certain (3, 6 -8) . Although consistent evidence shows that the adverse effect of obesity on mortality seems to diminish with increasing age, studies that have estimated the actual mortality risk posed by obesity in older adults have produced conflicting results. Some suggest that obesity confers either no added mortality risk or an attenuated risk, whereas others suggest a potential protective effect (6, 9, 10) . In addition, much of these data are derived from findings in largely white populations. Because of this uncertainty, weight control in elderly persons has been considered controversial, especially in light of early concerns about the safety of weight loss in older adults (9, 11) .
Other outcomes, such as functional independence and disability, are increasingly recognized as being as if not more salient than mortality among elderly persons (12, 13) . Evidence suggests a more consistent and stronger relationship between obesity and disability in this age group (14 -18) ; however, much of the previous work has been cross-sectional (17, 18) or has been conducted in convenience samples that may not be generalizable to the broader U.S. population of older adults (14 -16) . In addition, few studies have examined the influence of obesity on mortality and disability in the same cohort (14 -16) , and although evidence suggests that obesity has a lower adverse effect on mortality in African American than in white adults in the general U.S. population (3, 7), whether the effect of obesity on disability also varies between African American and older white adults is unknown.
In this context, we examined the prospective relationship between obesity and all-cause mortality and the development and progression of disability in a longitudinal cohort of Medicare beneficiaries. We hypothesized that obesity has a modest to negligible effect on mortality in this population but a substantial effect on functional decline. Our second goal was to characterize these relationships separately for men and women and for white and African American older adults, and explore whether the adverse effect of obesity is reduced in African American relative to white persons. Given the rapidly expanding elderly population and the increasing prevalence of overweight and obesity among older adults, a better understanding of the effect of obesity on mortality and disability in this population is relevant to both Medicare policy and health care planning. These data might also inform the current debate about the appropriateness of weight control in elderly Americans.
METHODS

Study Sample
We used data from the Medicare Current Beneficiary Survey, a nationally representative survey of the health and health care experiences of Medicare beneficiaries. For the survey, which was redesigned to its current form in 1994, respondents are interviewed 3 times a year over 4 years, for a total of 12 interviews. Baseline information, including demographic characteristics, health status (including height, weight, chronic medical conditions, and functional status), smoking history, and health care information, is gathered during the first interview and assessed annually. The year-4 interviews verify previous information; thus, longitudinal data on many outcomes are available for up to 3 consecutive years for each respondent (except for functional status, which was assessed only in the first 2 years of follow-up). These data are linked to Medicare claims files for respondents who had fee-for-service Medicare coverage (about 80% of the study sample) for the entire follow-up. With additional approval, we also linked the survey results to Medicare enrollment files to ascertain vital status and date of death through 22 April 2008.
Each fall, about one third of the sample is retired and replaced by 6000 new participants to maintain 3-year longitudinal data on approximately 12 000 persons at any given time. The response rate is typically 85% for new respondents, including 15% who designate a proxy respondent. In subsequent rounds, response rates usually exceed 90%. For analytic purposes, sampling weights are provided that account for the complex sampling design and for nonresponse, which allows results to be generalized to the U.S. Medicare population.
Our study included data from 20 975 respondents, interviewed at baseline between 1994 and 2000, who were aged 65 years or older and community-dwelling at the time of their baseline interview.
All-Cause Mortality
We calculated time to death from the date of the initial baseline interview until death or 22 April 2008, which provided us with up to 14 years of follow-up data on mortality. Respondents who were alive at this follow-up date were censored.
Functional Status and Disability
At baseline and annually for 2 years thereafter, respondents were asked whether they had any difficulty performing 6 activities of daily living (ADLs) (bathing or showering, dressing, eating, getting in and out of chairs, walking, and toileting) and 6 instrumental activities of daily living (IADLs) (using the telephone, doing light housework, doing heavy housework, making meals, shopping, and managing money). We categorized respondents' level of disability at baseline in terms of their difficulty performing ADLs and IADLs separately. We first categorized respondents by whether they reported any difficulty with ADLs or IADLs; respondents who reported "bedridden" for a specific ADL or "does not do" for a specific IADL were categorized as having either ADL or IADL difficulty. Those with 3 or more missing values for the 6 ADL or IADL questions (Ͻ15 respondents each) were excluded; however, respondents who reported difficulty with at least 1 ADL or IADL were classified as having disability, regardless of how many other responses were missing. We also categorized respondents on the basis of the number of ADLs or IADLs that they reported difficulty in performing (0, 1, 2, or Ն3). Severe difficulty was defined as difficulty with 3 or more ADLs or IADLs.
Context
Studies of obesity in older Americans have chiefly focused on its effects on mortality.
Contribution
In a survey of Medicare recipients, patient reports of new or worsening disability increased in a dose-related manner as body mass index (BMI) increased above the normal range. However, only older adults with markedly elevated BMIs had increased all-cause mortality.
Caution
Data were limited to participant self-reports. Reported risk for disability with increasing weight was less pronounced among African American than white persons; however, differences were not statistically significant.
Implication
Older obese adults may be an appropriate target group for interventions to prevent or decrease disability.
-The Editors
Original Research Obesity, Race, and Risk for Death or Disability Among Elderly Persons We characterized our outcome of functional decline in terms of ADL and IADL disability separately, on the basis of reports of new difficulties performing ADLs or IADLs during the annual follow-up interviews. We classified respondents as having developed a new ADL disability if they did not report ADL disability at baseline but reported ADL disability at at least 1 of the follow-up interviews. Among respondents with preexisting ADL disabilities, those who developed difficulty performing at least 1 additional ADL during follow-up were categorized as having progression of their ADL disability. Similarly, we classified respondents as having new IADL disability if they reported no ADL or IADL disability at baseline but reported difficulty performing at least 1 IADL at follow-up. Among respondents with preexisting difficulties in performing IADLs, progression in IADL disability was defined as having difficulty performing an additional IADL activity.
Body Weight
We used self-reported baseline height and weight to calculate body mass index (BMI), which we classified as underweight (Ͻ18. . These categories were guided in part by National Institutes of Health classifications (2) . We subdivided the normal and overweight categories into 2 subcategories to allow us to explore the BMI range of lowest risk, which previous literature has suggested may be higher in elderly persons than in the general adult population (6, 9, 10).
Demographic Factors, Smoking, and Comorbid Conditions
Respondents were also asked about their age, smoking status (never, former, or current), education level, and chronic health conditions. Comorbid conditions that were systematically elicited included hypertension, coronary heart disease (including myocardial infarction and angina), other heart conditions, stroke, diabetes, arthritis, mental retardation, Parkinson disease, chronic lung disease (chronic obstructive pulmonary disease, emphysema, or asthma), partial paralysis, loss of arm or leg, hip fracture, and various types of cancer. Data on comorbid conditions were also available through Medicare claims for most participants who had feefor-service insurance.
Statistical Analysis
Bivariate statistics were used to characterize our sample and outcome measures in terms of BMI and other factors. We used the Wald chi-square test to evaluate for differences in proportions and the t test to evaluate for differences in continuous variables.
To assess the relationship between BMI and all-cause mortality, we calculated race-and sex-specific mortality rates, standardized for age and smoking status by direct standardization to the sample; 95% CIs were generated by bootstrapping. Adjusted Cox proportional hazards regression models were then developed to examine time to death. The 945 respondents who died in the first 12 months were excluded, because their BMI at the initial interview probably reflected a lower weight than their true baseline weight because of the unintentional weight loss frequently associated with terminal illness. Because both sex-and racespecific differences were of interest, we tested for sex-BMI and race-BMI interactions. Sex-and race-specific estimates are reported separately but are derived from models that included a BMI-sex-race interaction.
To study the relationship between obesity and disability, we developed longitudinal logistic models by using generalized estimating equations to estimate the association between baseline BMI and functional decline in terms of ADL and IADL separately. Adjusted risk ratios and associated SEs and 95% CIs were estimated on the basis of the conditional marginal estimates of the outcome (functional decline in ADLs or IADLs) for each race-, sex-, and BMIspecific group, compared with the conditional marginal estimate of the race-and sex-specific BMI reference group. The CIs for these estimates were calculated on the log scale, and SEs and 95% CIs were approximated by using first-order Taylor series approximation. Functional decline was defined as new or worsening ADL or IADL disability over time, from baseline to follow-up at year 1 or from year 1 to year 2. Within-participant correlation was estimated and accounted for. Participants with severe disability were excluded at baseline to allow room for decline over time. Participants who died in the first year were excluded from these analyses, and those who died between years 1 and 2 were excluded for that time point. In sensitivity analyses, respondents who died between years 1 and 2 (609 for ADL and 472 for IADL analyses) were redefined as having developed new or worsening disability.
For all analyses, we adjusted models for baseline age, smoking status, education, and proxy response, as well as for chronic health conditions that were systematically elicited at the baseline interview and thought to be associated with mortality (19) but not believed to be in the causal pathway between obesity and mortality. These conditionschronic lung disease, rheumatoid arthritis, conditions associated with cognitive impairment (dementia, mental retardation, or Alzheimer or Parkinson disease), and cancer-are also components of the Charlson Comorbidity Index, which has been validated to predict mortality in other studies (19) . Our primary model included conditions assessed at the baseline interview. The small number of respondents with HIV or AIDS (Ͻ15 respondents) were excluded on the basis of claims information.
We weighted results to reflect national estimates, and we used SAS-callable (SAS Institute, Cary, North Carolina) SUDAAN statistical software (RTI International, Research Triangle Park, North Carolina) to account for the change in SE as a result of the complex design.
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Role of the Funding Source
Our study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases. The funding source had no role in the design, conduct, or analysis of our study or in the decision to submit the manuscript for publication.
RESULTS
Sample Characteristics
Of the 21 231 community-dwelling respondents, 256 were excluded because of missing data on BMI, mortality, or major demographic variables. Of the remaining 20 975 in our study sample, 11 093 (48%) died during the 14-year follow-up for mortality; 21% died within 5 years. The mean follow-up period for our disability outcomes was 1.8 years. Table 1 presents the baseline characteristics of our sample by weight status. African American respondents were disproportionately more likely to be obese. Unadjusted mortality rates were significantly higher in normalweight adults than in those with a higher BMI.
BMI, Race, and Mortality
Figure 1 presents BMI-associated mortality rates by sex and race, adjusted for age and smoking status, after the 945 respondents who died in the first 12 months were excluded. For all groups studied, the respondents with the lowest mortality had BMIs in the overweight range. . This pattern was true for white men and women in particular. In African American men, a higher BMI did not confer higher mortality risk at any level ( Figure 2 , top); in African American women, the risk estimates were similar to those for white women, but results were not statistically significant. We detected a statistically significant interaction between BMI and sex (P ϭ 0.031) but not between BMI and race (P ϭ 0.171).
We conducted several additional sensitivity analyses, specified a priori, to establish the stability of our findings. Additional adjustment for census region did not alter our primary results related to mortality. Our results also did not substantially differ when respon- Responded by proxy, n (%) 1806 (8) 159 (8) 836 (8) 574 (7) 237 (6) Mortality, n (%) 2 y 1935 (8) 230 (26) 970 (9) 501 (6) 234 (6) 5 y 5194 (21) 451 (51) 2578 (25) 1484 (17) 681 (18) Rates are derived through direct standardization with applied survey weights. BMI ϭ body mass index.
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Obesity, Race, and Risk for Death or Disability Among Elderly Persons www.annals.orgdents who used a proxy respondent were excluded. For the 15 915 respondents with linked claims information, we adjusted for conditions ascertained from diagnostic codes on Medicare claims. This model also included adjustments for chronic renal failure. Further adjustments were made for diagnoses from self-report or Medicare claims that were noted at any time during the 2-year follow-up, to capture preexisting but potentially unrecognized comorbid conditions. The results of these analyses were largely consistent with our primary find- ≥35.0* Adjusted hazard ratios for death (top) and adjusted risk ratios for developing new or progressive ADL (middle) or IADL (bottom) disability. Death was assessed at up to 14 y from the baseline interview. Disability was assessed at 1 and 2 y after the baseline interview. All models were adjusted for baseline age, smoking status, highest education, proxy response, and individual non-obesity-related comorbid conditions (chronic lung disease, rheumatoid arthritis, cognitive impairment, and cancer); a few persons with HIV or AIDS (Ͻ15 respondents) were excluded. Models included a BMI-race-sex interaction term, with a BMI of 22.0 -24.9 kg/m 2 used as the reference category within each race-or sex-specific comparision. ADL ϭ activity of daily living; BMI ϭ body mass index; IADL ϭ instrumental activity of daily living. * Fewer than 30 African American respondents in the sample were in this BMI category. † Analyses excluded respondents with any ADL disability at baseline, as well as those in the underweight (Ͻ18.5 kg/m 2 ) BMI category (because of zero sample sizes).
Original Research Obesity, Race, and Risk for Death or Disability Among Elderly Persons ings (data not shown). Although observational studies have shown many types of cancer to be associated with obesity, our primary model was adjusted for cancer because those causal links are often not clearly established. In sensitivity analyses that excluded breast, colon, uterine, and prostate cancer, for which the link to obesity was particularly strong, results were largely similar (data not shown). Finally, we tested for effect modification between BMI and smoking status separately; the interaction was not statistically significant (P ϭ 0.80).
Because the association between BMI and mortality has a well-known U shape, we developed models to examine the BMI-mortality association for respondents with a BMI greater than 25.0 kg/m 2 . For these analyses, our reference group was the group with the lowest observed risk for death in our primary analyses (those with a BMI of 25.0 to 27.4 kg/m 2 ). The test for trend for the relationship between BMI and mortality was significant for white men (P ϭ 0.001) and women (P Ͻ 0.001); this trend was driven largely by the higher risk associated with a BMI of 35 kg/m 2 or greater. In men, the HRs were 0.98 (CI, 0.87 to 1.10) for a BMI of 27.5 to 29.9 kg/m 2 , 1.07 (CI, 0.95 to 1.21) for a BMI of 30.0 to 34.9 kg/m 2 , and 1.81 (CI, 1.41 to 2.32) for a BMI greater than 35.0 kg/m 2 . In women, the respective HRs were 0.93 (CI, 0.83 to 1.03), 1.12 (CI, 1.00 to 1.26), and 1.38 (CI, 1.16 to 1.61). The test for trend was not significant for African American men and women, and the interaction between BMI and race was also not statistically significant (P ϭ 0.23).
BMI, Race, and Disability
Tables 2 and 3 present the unadjusted relationship between BMI and disability at baseline and follow-up; 27% of the overall sample had ADL disability and 43% had IADL disability at baseline. Body mass index was significantly associated with the presence of both ADL and IADL disability at baseline. The baseline prevalence of ADL and IADL disability were also substantially higher in African American than in white persons in almost every BMI category (P ϭ 0.020 in men and P Ͻ 0.001 in women for racial differences in proportions of ADL prevalence; P Ͻ 0.004 in men and P Ͻ 0.001 in women for racial differences in proportions of IADL prevalence). Among respondents without severe disability at baseline, 17% developed new or worsening ADL disability and 26% developed new or worsening IADL disability within 2 years. Body mass index was also significantly associated with the development of new or progressive ADL and IADL disability at follow-up except among African American men (Table 2 and 3) . Furthermore, among men and women without ADL disability (n ϭ 13 489) and IADL disability (n ϭ 10 321) at baseline, BMI was also significantly associated with the development of new disability. , and 23% for those with a BMI of 35.0 kg/m 2 or higher (P Ͻ 0.001). At 2 years, the respective estimates were 13%, 13%, 16%, 19%, and 27% (P Ͻ 0.001). The incidence estimates of new IADL disability at 1 year were 18%, 18%, 20%, 22%, and 29% for the respective BMI groups (P ϭ 0.002). At 2 years, the respective incidence estimates were 23%, 22%, 24%, 28%, and 36% (P Ͻ 0.001). Tables 1 and 2 present more information.) We excluded 2% of the eligible sample for each of these analyses because of missing data. In contrast to its relationship with mortality, above-normal BMI was associated with new or progressive ADL and IADL disability in a dosedependent manner in both men and women (P ϭ 0.009 for the interaction between BMI and sex). The relationship between obesity and new or progressive ADL disability was attenuated in African American relative to white persons, although the BMI-race interaction (Figure 2, middle) was not significant (P ϭ 0.23). In contrast, the relationship between obesity and IADL disability was more consistent between men and women and between white and African American persons; the interactions between BMI and sex (P ϭ 0.86) and BMI and race (P ϭ 0.84) were not statistically significant. As with our mortality analyses, additional adjustments for census region, proxy response, or conditions abstracted from claims data in the first 12 months of the baseline interview did not alter our primary findings. Similar results were found when respondents who died between years 1 and 2 were reclassified as having new or worsening disability (Appendix Table 3 , available at www.annals.org).
Among respondents with a BMI greater than 25 kg/ m 2 , the test for trend for the outcome of new or progressive ADL disability was significant for white men (P Ͻ 0.001), white women (P Ͻ 0.001), and African American women (P ϭ 0.012) in a dose-dependent manner but not for African American men (P ϭ 0.44); however, the interaction between BMI and race (P ϭ 0.58) was not significant. Tests for trend in the relationship between higher BMI and IADL disability were also significant for both white men (P ϭ 0.01) and white women (P ϭ 0.001) but not for African American men (P ϭ 0.42) or African American women (P ϭ 0.16); racial differences were not statistically significant.
DISCUSSION
We found that after up to 14 years of follow-up among Medicare recipients aged 65 years or older, a BMI above the normal range was associated with allcause mortality only among those with a BMI of 35 Original Research Obesity, Race, and Risk for Death or Disability Among Elderly Persons kg/m 2 or greater. This was particularly true for white men and women; no level of obesity was significantly associated with premature death among African American men and women, although the differences between white and African American older adults were not statistically significant. In contrast, older adults with a BMI even modestly above the normal range were more likely to develop new or worsening disability over the intervening 1 to 2 years. This association was particularly pronounced for disability related to ADLs. The estimates for the relationship between obesity and ADL disability seemed weaker in African American than in white persons; however, these racial differences were also not statistically significant.
To our knowledge, ours is the largest longitudinal study to date to examine the association between obesity and both mortality and disability in a nationally representative cohort of community-dwelling Medicare beneficiaries aged 65 years or older. Previous studies on the influence of age on the obesity-mortality relationship (6, 9, 10) have suggested that the adverse effect of obesity diminishes with advancing age. However, estimates of the actual mortality risk posed by obesity have varied across studies (6) . A recent systematic review and metaanalysis of 32 studies by Janssen and Mark (6) found that obesity, as defined by BMI, was associated with higher mortality in 13 subgroups of participants aged 65 years or older and with lower mortality in another 13 subgroups; no association was detected in the remaining groups. These studies were methodologically diverse, with most consisting of convenience samples of predominantly white participants, and their sample sizes ranged from a few hundred to a few thousand elderly participants. As with our study, most trials relied on selfreported height and weight. In their meta-analysis, Janssen and Mark estimated an associated mortality risk of 1.00 (CI, 0.97 to 1.03) for overweight and 1.10 (CI, 1.06 to 1.13) for obesity. They concluded that overweight was not associated with mortality and that moderate obesity was associated with a modest increase in mortality. Our findings are consistent with their conclusions, although our estimates are not directly comparable because Janssen and Mark did not estimate the risks associated with mild and moderate obesity separately.
Several factors may contribute to the apparent attenuation in obesity-related mortality risk in older relative to younger adults (20) . This lower risk may reflect a survivor effect, in which susceptible persons have already died and the remaining obese persons included in studies of elderly populations are more resistant to the adverse consequences of obesity. The competing mortality risks and shortened life expectancy of elderly patients can also effectively shorten both the follow-up of a study and its ability to establish the obesity-mortality relationship. In addition, confounding is a greater problem among older adults; an older person's BMI as measured for a study may differ from his or her true lifetime BMI because of weight loss associated with illness, chronic disease, or unhealthy behaviors. Although we addressed this in our study, residual confounding probably occurred. Another possible explanation may be that BMI is a poorer measure for adiposity as persons age, lose muscle mass, and gain adipose tissue (21, 22) . Some studies (22) suggest that waist circumference and waisthip ratio may be a better measure than BMI alone; however, evidence suggests that when waist circumference is studied independently of BMI, it predicts mortality to a similar extent and its predictive ability also diminishes with age (10) .
Despite the problems with using BMI as a measure of obesity and adiposity, our results confirm the findings of previous work, which suggests a strong and consistent adverse effect of obesity on both disability and functional independence in elderly persons (14 -16) . Previous studies have varied methodologically; many were cross-sectional (17, 18) , and the longitudinal studies often comprised convenience samples and focused on outcomes in the longer term (14, 15, 23) . A few studies have used the same cohort to examine the influence of obesity on both mortality and disability in elderly persons. Al Snih and colleagues (15) analyzed data from 5 U.S. communities in the EPESE (Established Populations for Epidemiologic Studies of the Elderly) study and found that the BMI with the lowest hazard for mortality was 27 kg/m 2 , whereas a BMI of 24 kg/m 2 had the lowest hazard for disability after 7 years of follow-up. A longitudinal study of 3793 English participants followed for 5 years (16) found that the RR of ADL disability was 1.99 (CI, 1.42 to 2.78) for obesity and 5.26 (CI, 2.21 to 9.97) for severe obesity among men; among women, the respective RRs were 1.66 (CI, 1.25 to 2.19) and 2.69 (CI, 1.81 to 4.01). Of note, our findings demonstrate that obesity can affect disability even in a follow-up period of only 2 years and point to the large adverse effect of obesity on the lives of older adults even after the limitations of using an imperfect surrogate measure are acknowledged.
Taken together, our findings suggest a need for greater attention to the morbidity and disability posed by obesity in elderly persons. The role of weight loss in this population has been controversial. Weight loss can lead to reduction of bone mineral density and concerns about malnutrition (11) , although a recent systematic review of weight loss interventions in elderly adults (9) suggests that this effect may be small. Several studies and a systematic review (9, 11, 24, 25) suggest that weight loss interventions can improve muscle strength, pain symptoms, and overall physical functioning, particularly when exercise is a component of the intervention. Whether advising weight loss is warranted in obese older adults, and whether it would reduce the risk for new or progressive disability, requires further study. Other weight-neutral interventions that focus on improving mobility and physical functioning, such
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Our study has limitations. Much of the data are selfor proxy-reported and are subject to recall bias and misclassification (27) . Height and weight reporting may be particularly inaccurate for persons who have not recently seen a health provider or been weighed; reporting may also vary by age and race (28) . As mentioned, BMI is a suboptimal proxy for adiposity in older adults (21, 22) ; however, it is more easily and commonly assessed clinically, and our findings suggest that it is still useful for identifying elderly adults who are most at risk for functional decline. Finally, our sample size of African Americans and other racial groups was relatively modest, which may have limited our ability to detect small but meaningful differences between white and African American respondents. Whether our primary findings apply uniformly across racial and ethnic groups is also unknown.
In summary, obesity (as measured by BMI) seems to confer added mortality risks in elderly persons only when BMI is 35 kg/m 2 or greater; however, more modestly elevated BMIs above the normal range seem to predict functional decline in a 2-year period among communitydwelling elderly persons in the United States. We did not detect statistically significant differences between white and African American older adults, although risk estimates for ADL disability associated with obesity seemed lower in African American than in white adults. Future studies are needed to develop and test interventions aimed at reducing disability in older adults with obesity. ADL ϭ activity of daily living; BMI ϭ body mass index; IADL ϭ instrumental activity of daily living. * Death was assessed at up to 14 y from the baseline interview. Disability was assessed at 1 and 2 y after the baseline interview. All models were adjusted for baseline age, smoking status, highest education, proxy response, and individual non-obesity-related comorbid conditions (rheumatoid arthritis, cancer, cognitive impairment, and chronic lung disease); a few persons with HIV or AIDS (Ͻ15 respondents) were excluded. Models included a BMI-race-sex interaction and incorporated sample weights to reflect population estimates. † Fewer than 30 African American respondents in the sample were in this BMI category. ‡ Analyses excluded respondents with any ADL disability at baseline, as well as those in the underweight (Ͻ18.5 kg/m 2 ) BMI category.
